## Review setup
- **Input scope** Abstract only
- **Assessment boundary** Claims and evidence presented in the supplied abstract
- **Shared manuscript claim summary** The authors describe DisoRDPbind, a web server for predicting RNA-binding intrinsically disordered regions (IDRs), and discuss its predictive performance, runtime, and utility, including a case study on the HCV core protein as an RNA chaperone.
- **Visible evidence base** Abstract text only; no figures, tables, methods details, or performance data are provided
- **Missing materials affecting confidence** Full manuscript, method description, performance metrics, web server interface details, case study results, and any validation data

## Reviewer
- **Overall assessment** The abstract presents a concise overview of a potentially useful bioinformatics tool for a niche but growing area of research. However, the supplied material is insufficient to evaluate the technical soundness, predictive performance claims, or the validity of the case study. The abstract reads as a methods chapter summary rather than a primary research contribution, and the evidence base is too limited to assess the core claims.
- **Who would be interested in the results, and why** Researchers studying intrinsically disordered proteins, RNA biology, and RNA chaperones would find this tool relevant. Computational biologists developing or benchmarking predictors of molecular binding in IDRs may also be interested, particularly those working on RNA-protein interactions. The proteome-scale prediction capability could appeal to researchers conducting large-scale genomic or proteomic analyses.
- **Major strengths** The abstract identifies a clear gap in the field, namely the scarcity of predictors for RNA-binding IDRs. The emphasis on computational efficiency and proteome-scale applicability is a practical strength. The inclusion of a case study on an RNA chaperone demonstrates an attempt to connect the tool to biological function.
- **Major Concerns**  
  - **Concern ID** R1-M1  
    **Severity** Major  
    **Blocking** Yes  
    **Axis** Technical soundness  
    **Claim pointer** The abstract claims that DisoRDPbind's predictive performance and runtime were "recently measured in the second CAID experiment," implying validated performance.  
    **Evidence pointer** Abstract text; location not provided  
    **Concern** No performance metrics, benchmark results, or comparative data are presented in the supplied material. The claim of measured performance in CAID is stated without any numerical support or context.  
    **Why it matters** Without quantitative evidence, the reader cannot assess whether the tool is accurate, reliable, or competitive with existing methods. The claim of CAID evaluation is unverifiable from the abstract alone.  
    **Resolution test** Provide the actual performance metrics (e.g., AUC, precision, recall, Matthews correlation coefficient) from the CAID experiment, along with a comparison to other predictors, in the full manuscript.
  - **Concern ID** R1-M2  
    **Severity** Major  
    **Blocking** Yes  
    **Axis** Scientific importance  
    **Claim pointer** The abstract implies that DisoRDPbind is one of the first tools for RNA-binding IDR prediction, suggesting novelty and importance.  
    **Evidence pointer** Abstract text; location not provided  
    **Concern** The abstract does not provide a literature context or a systematic comparison to existing tools. The claim of being "one of the first" is not substantiated with citations or a survey of the field.  
    **Why it matters** The novelty and contribution of the tool cannot be evaluated without understanding the existing landscape of RNA-binding IDR predictors.  
    **Resolution test** Include a brief literature review in the full manuscript that identifies prior tools and clearly articulates what DisoRDPbind adds beyond them.
  - **Concern ID** R1-M3  
    **Severity** Major  
    **Blocking** Yes  
    **Axis** Technical soundness  
    **Claim pointer** The abstract states that the case study of the HCV core protein "illustrates the method's utility in studying RNA chaperones."  
    **Evidence pointer** Abstract text; location not provided  
    **Concern** No details of the case study are provided, including the input data, prediction results, or how these results inform RNA chaperone biology. The claim of utility is therefore unsupported.  
    **Why it matters** The case study is presented as a demonstration of biological relevance, but without results or interpretation, it cannot be assessed.  
    **Resolution test** Provide the case study details in the full manuscript, including the predicted RNA-binding regions in HCV core protein and a discussion of how these predictions align with known or hypothesized chaperone functions.
- **Minor Comments**  
  - **Concern ID** R1-m1  
    **Severity** Minor  
    **Axis** Readability for nonspecialists  
    **Affected element** Abstract text  
    **Evidence pointer** Abstract text  
    **Issue** The abstract assumes familiarity with IDR prediction and CAID, which may limit accessibility for readers outside the computational biology field.  
    **Required correction** Briefly define IDRs and CAID in the abstract or introduction to broaden accessibility.
  - **Concern ID** R1-m2  
    **Severity** Minor  
    **Axis** Reproducibility  
    **Affected element** Web server access  
    **Evidence pointer** Abstract text  
    **Issue** The web server URL is provided, but there is no mention of data availability, input format requirements, or output interpretation guidelines beyond a single example.  
    **Required correction** In the full manuscript, include clear instructions on input formats, output fields, and any limitations on data size or sequence length.
  - **Concern ID** R1-m3  
    **Severity** Minor  
    **Axis** Interdisciplinary readership  
    **Affected element** Case study framing  
    **Evidence pointer** Abstract text  
    **Issue** The connection between RNA-binding IDR prediction and RNA chaperone function is stated but not explained, which may confuse readers unfamiliar with chaperone biology.  
    **Required correction** Add a brief explanation of how RNA-binding IDRs relate to chaperone activity in the full manuscript.
- **Technical failings that need to be addressed before the case is established** R1-M1, R1-M2, R1-M3. The absence of performance data, literature context, and case study results means the core claims of the abstract are not verifiable from the supplied material.
- **Assessment against Nature-style criteria**  
  - Originality: The abstract suggests a niche tool, but without a literature survey, originality cannot be confirmed.  
  - Scientific importance: The topic is relevant, but the significance is not demonstrated with evidence.  
  - Interdisciplinary readership: The abstract may appeal to computational biologists and RNA researchers, but the lack of context limits broader appeal.  
  - Technical soundness: Not assessable from the abstract; no methods or performance data are provided.  
  - Readability for nonspecialists: The abstract is concise but assumes domain knowledge, reducing accessibility.
- **Recommendation posture** Currently not established from the provided evidence. The abstract alone does not provide sufficient information to evaluate the tool's validity, performance, or biological utility. A full manuscript with methods, results, and validation data would be required to assess the claims.

## Risk / unsupported claims
- The claim that DisoRDPbind's performance was "recently measured in the second CAID experiment" is unsupported without specific metrics or a citation.
- The claim that DisoRDPbind is "one of the first tools" for RNA-binding IDR prediction is unsubstantiated without a literature review.
- The case study of HCV core protein is mentioned but not described, making the claim of utility unverifiable.
- The statement that the tool "allows for large/proteome-scale predictions" is plausible but not supported by any runtime or scalability data in the abstract.